Bio Essence (BIOE) Cash from Investing Activities (2020 - 2022)

Bio Essence's Cash from Investing Activities history runs 3 years deep, the most recent figure standing at -$5527.0 for Q4 2022.

• In Q4 2022, Cash from Investing Activities rose 93.85% year-over-year to -$5527.0; the TTM figure through Dec 2023 stood at -$147427.0 (up 5.77% YoY), while the FY2024 annual figure was -$114.0, up 96.85% from the prior year.
• Cash from Investing Activities was -$5527.0 for Q4 2022 at Bio Essence, up from -$52053.0 in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of -$5527.0 in Q4 2022 to a low of -$89847.0 in Q4 2021.
• Historically, Cash from Investing Activities has averaged -$25732.0 across 3 years, with a median of -$9020.0 in 2021.
• The sharpest annual moves came in 2021 and 2022: Cash from Investing Activities slumped 1463.1% in 2021, then jumped 93.85% in 2022.
• A 3-year view of Cash from Investing Activities shows it stood at -$5748.0 in 2020, then plunged by 1463.1% to -$89847.0 in 2021, then surged by 93.85% to -$5527.0 in 2022.
• The last three Cash from Investing Activities figures came in at -$5527.0 (Q4 2022), -$52053.0 (Q3 2022), and -$89847.0 (Q4 2021), per Business Quant data.